- April 29, 2020Model Demonstrated Cost Effectiveness in Test Use on Patients Suspected of Acute Respiratory Tract Infections in American Emergency Department Setting…
- April 16, 2020Burlingame, Calif., April 16, 2020 — Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today…
April 1, 2020
March 19, 2020- March 18, 2020Palo Alto, Calif., March 18, 2020 — 70+ StartX Med Innovators with Medical Breakthroughs for the Prevention, Diagnostics and Treatment of Coronavirus…
- March 18, 2020
- March 9, 2020
- March 4, 2020Burlingame, Calif., March 4, 2020 — Novel Machine Learning Host-Response-Based Approach Forms the Basis of Company’s Tests. Inflammatix, a pioneering molecular diagnostics company…
- January 10, 2020Burlingame, Calif., January 10, 2020 — Financing will be used to advance HostDx™ tests for acute infections and sepsis to commercial launch…
- January 10, 2020
